Ignite Creation Date:
2024-05-06 @ 2:29 AM
Last Modification Date:
2024-10-26 @ 11:19 AM
Study NCT ID:
NCT02053636
Status:
COMPLETED
Last Update Posted:
2020-01-03
First Post:
2014-01-24
Brief Title:
A Phase II Trial Testing Oral Administration of Lucitanib in Patients With Fibroblast Growth Factor Receptor FGFR1-amplified or Non-amplified Estrogen Receptor Positive Metastatic Breast Cancer
Sponsor:
Organization:
Servier